Efficacy, effectiveness and safety of nasal glucagon as rescue therapy for severe hypoglycaemia in children and adolescents with Type 1 diabetes

被引：0
|
作者：
Balogh, E. [1 ]
Reviriego, J. [2 ]
Thieu, V. T. [3 ]
Jiletcovici, A. [3 ]
机构：
[1] Eli Lilly & Co, Med Diabet, Basingstoke, Hants, England
[2] Eli Lilly & Co, Med Diabet, Madrid, Spain
[3] Eli Lilly & Co, Med Affairs, Indianapolis, IN 46285 USA
来源：
DIABETIC MEDICINE | 2019年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P307
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [21] EEG abnormalities with and without relation to severe hypoglycaemia in adolescents with type 1 diabetes
    Hyllienmark, L
    Maltez, J
    Dandenell, A
    Ludvigsson, J
    Brismar, T
    [J]. DIABETOLOGIA, 2005, 48 (03) : 412 - 419
  • [22] Frequency and correlates of severe hypoglycaemia in children and adolescents with diabetes mellitus
    Bognetti, E
    Brunelli, A
    Meschi, F
    Viscardi, M
    Bonfanti, R
    Chiumello, G
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1997, 156 (08) : 589 - 591
  • [23] Frequency and correlates of severe hypoglycaemia in children and adolescents with diabetes mellitus
    E. Bognetti
    A. Brunelli
    F. Meschi
    M. Viscardi
    R. Bonfanti
    G. Chiumello
    [J]. European Journal of Pediatrics, 1997, 156 : 589 - 591
  • [24] Nasal glucagon: a viable alternative to treat insulin-induced hypoglycaemia in adults with type 1 diabetes
    Suico, J.
    Hoevelmann, U.
    Zhang, S.
    Shen, T.
    Bergman, B.
    Sherr, J.
    Zijlstra, E.
    Frier, B.
    Plum-Moerschel, L.
    [J]. DIABETOLOGIA, 2018, 61 : S77 - S78
  • [25] Determinants of Severe Hypoglycaemia in Type 1 Diabetes
    Julla, Jean-Baptiste
    Deboissieu, Paul
    Trecan, Tiphaine Vidal
    Bouche, Clara
    Kevorkian, Jean-Philippe
    Laloi, Marie
    Feron, Florine
    Salle, Laurence
    Juddoo, Vanessa
    Sarron, Tulio
    Leblanc, Herve
    Gautier, Jean-Francois
    Riveline, Jean-Pierre
    [J]. DIABETES, 2017, 66 : A109 - A109
  • [26] Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting
    Seaquist, Elizabeth R.
    Dulude, Helene
    Zhang, Xiaotian M.
    Rabasa-Lhoret, Remi
    Tsoukas, George M.
    Conway, James R.
    Weisnagel, Stanley J.
    Gerety, Gregg
    Woo, Vincent C.
    Zhang, Shuyu
    Carballo, Dolores
    Pradhan, Sheetal
    Piche, Claude A.
    Guzman, Cristina B.
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (05): : 1316 - 1320
  • [27] Long-term safety of α-1 antitrypsin therapy in children and adolescents with Type 1 diabetes
    Brener, Avivit
    Lebenthal, Yael
    Interator, Hagar
    Horesh, Orit
    Leshem, Avital
    Weintrob, Naomi
    Loewenthal, Neta
    Shalitin, Shlomit
    Rachmiel, Marianna
    [J]. IMMUNOTHERAPY, 2018, 10 (13) : 1137 - 1148
  • [28] A pilot study in adults with type 1 diabetes to examine the efficacy of stable non-aqueous liquid glucagon for treatment of severe hypoglycaemia
    Christiansen, M.
    Cummins, M.
    Prestrelski, S.
    Shi, L.
    Strange, P.
    [J]. DIABETOLOGIA, 2017, 60 : S338 - S338
  • [29] Nasal glucagon is safe and effective in children and adolescents with type 1 diabetes: A real-world prospective cohort study
    Zucchini, Stefano
    Ripoli, Carlo
    Cherubini, Valentino
    Coccioli, Maria Susanna
    Delvecchio, Maurizio
    De Marco, Rosaria
    Franceschi, Roberto
    Gallo, Francesco
    Graziani, Vanna
    Iafusco, Dario
    Innaurato, Stefania
    Lasagni, Anna
    Lombardo, Fortunato
    Marigliano, Marco
    Monti, Sara
    Pascarella, Filomena
    Pezzino, Giulia
    Predieri, Barbara
    Rabbone, Ivana
    Schiaffini, Riccardo
    Trada, Michela
    Tumini, Stefano
    Scaramuzza, Andrea
    [J]. DIABETES OBESITY & METABOLISM, 2024, 26 (02): : 754 - 757
  • [30] Insulin Therapy in Children and Adolescents with Type 1 Diabetes
    Faisal S. Malik
    Craig E. Taplin
    [J]. Pediatric Drugs, 2014, 16 : 141 - 150
12345